| For: | Wahab MA, El Hanafy E, El Nakeeb A, Ali MA. Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period). World J Gastrointest Surg 2017; 9(2): 61-67 [PMID: 28289511 DOI: 10.4240/wjgs.v9.i2.61] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v9/i2/61.htm |
| Number | Citing Articles |
| 1 |
Chiraz Ben-Salah, Philipp Mayer, Thomas Longerich, Miriam Klauß. Erkennung und Unterscheidung von atypischen hepatozellulären Karzinomen. Die Radiologie 2026; 66(6) doi: 10.1007/s00117-026-01623-5
|
| 2 |
Jyotsna Gummadi, Xin Wang, Changqing Xie. Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S406902
|
| 3 |
Cassandra A. Kersten, Elise N. Sloey, Eric Zhou, Ying Peng, Michael S. Torbenson, Yi Guo. Fibrolamellar hepatocellular carcinoma: Exploring molecular mechanisms and differentiation pathways to better understand disease outcomes and prognosis. Liver Research 2017; 1(4) doi: 10.1016/j.livres.2017.12.003
|
| 4 |
Lorenza Rimassa, Nicola Personeni, Carolin Czauderna, Friedrich Foerster, Peter Galle. Systemic treatment of HCC in special populations. Journal of Hepatology 2021; 74(4) doi: 10.1016/j.jhep.2020.11.026
|
| 5 |
Susan Shyu, Syed Z. Ali. Significance of hepatocyte atypia in liver fine needle aspiration. Diagnostic Cytopathology 2022; 50(4) doi: 10.1002/dc.24851
|
| 6 |
Hiroki Tanaka, Susumu Hijioka, Hiromichi Iwaya, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Ayako Ito, Naosuke Kuraoka, Shinpei Matsumoto, Masahiro Obata, Yusuke Kurita, Muneji Yasuda, Yasuhiro Shimizu, Hiroaki Kuroda, Yozo Sato, Masataka Haneda, Eiichi Sasaki, Yasushi Yatabe, Kazuo Hara. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy. Internal Medicine 2018; 57(24) doi: 10.2169/internalmedicine.1243-18
|
| 7 |
Mohamed El-Kassas, Walaa Abdelhamed. Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event. World Journal of Gastrointestinal Oncology 2022; 14(6): 1103-1114 doi: 10.4251/wjgo.v14.i6.1103
|
| 8 |
Sebastian Mafeld, Jeremy French, Dina Tiniakos, Beate Haugk, Derek Manas, Peter Littler. Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection. CardioVascular and Interventional Radiology 2018; 41(5) doi: 10.1007/s00270-018-1903-6
|
| 9 |
F. Lo Prinzi, S. Camera, S. Foti, M. Persano, C.M. Gullotta, F. Rossari, F. Vitiello, L. Passeri, F. Michele, A. Casadei-Gardini, M. Rimini. Clinical characteristics and outcome of patients with fibrolamellar hepatocellular carcinoma: an analysis of a large population using real-world data. ESMO Gastrointestinal Oncology 2025; 10 doi: 10.1016/j.esmogo.2025.100272
|
| 10 |
Georgios Polychronidis, Anastasia Murtha-Lemekhova, Juri Fuchs, Evdokia Karathanasi, Katrin Hoffmann. A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects. OncoTargets and Therapy 2022; doi: 10.2147/OTT.S296127
|
| 11 |
Andrew Melehy, Vatche Agopian. Treating rare tumors with liver transplantation. Current Opinion in Organ Transplantation 2024; 29(1) doi: 10.1097/MOT.0000000000001118
|
| 12 |
Daryl Ramai, Andrew Ofosu, Jonathan K. Lai, Zu-Hua Gao, Douglas G. Adler. Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study. Digestive Diseases and Sciences 2021; 66(1) doi: 10.1007/s10620-020-06135-3
|
| 13 |
Emina Talakić, Daniela Kniepeiss, Peter Schemmer. Rare Liver and Biliary Tract Diseases. 2026; doi: 10.1007/978-3-032-15076-9_15
|
| 14 |
D. Kyziridis, A. Kalakonas, K. Zarambouka, C. Hristakis, Antonios-Apostolos K. Tentes. Cytoreductive Surgery and HIPEC for Recurrent Fibrolamellar Hepatocellular Carcinoma with Peritoneal Carcinomatosis. Journal of Gastrointestinal Cancer 2020; 51(1) doi: 10.1007/s12029-019-00236-7
|
| 15 |
Mohammad Khavandi, Kevin Agahi, Sunyoung Lee, Ahmed Kaseb, Bruno Odisio, Mohamed Abdelsalam, Joshua Kuban, Rahul Sheth, Rony Avritscher, S Kappadath, Armeen Mahvash, Peiman Habibollahi. Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma: A Tertiary Cancer Center Experience. Journal of Hepatocellular Carcinoma 2026; doi: 10.2147/JHC.S546213
|
| 16 |
Anisha Jain, Benjamin Mazer, Yanhong Deng, Maria Ciarleglio, Dhanpat Jain, Tamar Taddei, Xuchen Zhang. Hepatocellular Carcinoma. American Journal of Clinical Pathology 2022; 157(2) doi: 10.1093/ajcp/aqab125
|
| 17 |
Sara Bedrose, Marilyne Daher, Lina Altameemi, Mouhammed Amir Habra. Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions. Cancers 2020; 12(2) doi: 10.3390/cancers12020508
|
| 18 |
Dajana Glavas, Quoc Riccardo Bao, Marco Scarpa, Cesare Ruffolo, Zachary J. Brown, Timothy M. Pawlik, Gaya Spolverato. Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis. Journal of Gastrointestinal Surgery 2023; 27(4) doi: 10.1007/s11605-023-05621-z
|
| 19 |
|
| 20 |
Allison F. O'Neill, Alanna J. Church, Antonio R. Perez-Atayde, Raja Shaikh, Karen J. Marcus, Khashayar Vakili. Fibrolamellar carcinoma: An entity all its own. Current Problems in Cancer 2021; 45(4) doi: 10.1016/j.currproblcancer.2021.100770
|
| 21 |
Akira Watanabe, Norifumi Harimoto, Hideyuki Saito, Reika Kawabata-Iwakawa, Takaomi Seki, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Kenichiro Araki, Hayato Ikota, Takashi Ishige, Koshi Mimori, Ken Shirabe. Fibrolamellar hepatocellular carcinoma: a case report and gene analysis. Surgical Case Reports 2023; 9(1) doi: 10.1186/s40792-023-01751-3
|
| 22 |
Gozde Ozer, H. Nursun Ozcan, Burak Ardicli, Tezer Kutluk, Berna Oguz, Mithat Haliloglu. Radiological and clinical signatures to differentiate hepatocellular carcinoma from hepatoblastoma in children older than 5 years of age: a feasibility study. Pediatric Radiology 2025; 55(5) doi: 10.1007/s00247-025-06190-w
|
| 23 |
Cassandra A. Kersten, Elise N. Sloey, Eric Zhou, Ying Peng, Michael S. Torbenson, Yi Guo. WITHDRAWN: Fibrolamellar hepatocellular carcinoma: Exploring molecular mechanisms and differentiation pathways to better understand disease outcomes and prognosis. Liver Research 2018; doi: 10.1016/j.livres.2017.12.011
|
| 24 |
Tiantian Fu, Hong Ding, Chen Xu, Yuli Zhu, Liyun Xue, Feng Lin. Imaging findings of fibrolamellar hepatocellular carcinomas on ultrasonography: A comparison with conventional hepatocellular carcinomas1. Clinical Hemorheology and Microcirculation 2021; 77(1) doi: 10.3233/CH-200896
|
| 25 |
SAM SON, AKSHAAR BRAHMBHATT, KEN ZHAO, BRETT MARINELLI, JAMES HARDING, WILLIAM JARNAGIN, GHASSAN K. ABOU-ALFA, HOOMAN YARMOHAMMADI. Liver-directed therapies for fibrolamellar carcinoma: A single-center experience. Oncology Research 2024; 32(12) doi: 10.32604/or.2024.052985
|
| 26 |
Ryota Matsuki, Naohiro Okano, Nobuhiro Hasui, Shohei Kawaguchi, Hirokazu Momose, Keiichiro Kitahama, Kiyotaka Nagahama, Masaharu Kogure, Yutaka Suzuki, Fumio Nagashima, Junji Shibahara, Hideaki Mori, Yoshihiro Sakamoto. Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression. Liver Cancer 2023; 12(2) doi: 10.1159/000527250
|
| 27 |
Shaotian Qiu, Rui Chen, Jiaxuan Hu, Tao Han. The prognosis of fibrolamellar carcinoma versus conventional hepatocellular carcinoma: a study based on propensity score matching. Scandinavian Journal of Gastroenterology 2023; 58(11) doi: 10.1080/00365521.2023.2227305
|